fampyra 10 mg
medison pharma ltd - fampridine - tablets prolonged release - fampridine 10 mg - fampridine - fampridine - fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7)
fampyra
biogen netherlands b.v. - fampridine - multiple sclerosis - other nervous system drugs - fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (expanded disability status scale 4-7).
fampyra 10mg modified-release tablets
biogen idec ltd - fampridine - modified-release tablet - 10mg
fampridine accord
accord healthcare s.l.u. - fampridine - multiple sclerosis - other nervous system drugs - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
fampridine rontis 10mg prolonged-release tablets
rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - fampridine - prolonged-release tablet - fampridine 10 mg - other nervous system drugs
fampridine rowa 10 mg prolonged-release tablets
rowa pharmaceuticals limited - fampridine - prolonged-release tablet - fampridine
fampyra tablet (extended-release)
biogen canada inc - fampridine - tablet (extended-release) - 10mg - fampridine 10mg - other miscellaneous therapeutic agents
4-aminopyridine 10mg capsules
special order - fampridine - oral capsule - 10mg
fampyra 10mg prolonged-release tablet tablet, extended release
biogen idec, united kingdom - fampridine (4-aminopyridine) - tablet, extended release - 10 mg
pemar 10 mg prolonged-release tablet prolonged-release tablet
tabuk pharmaceutical manufacturing company, saudi arabia - dalfampridine - prolonged-release tablet - 10 mg